No Severe Adverse Effects from Intravitreally Injected Putative Adipose Tissue-Derived Stem Cells

Research output: Contribution to journalJournal articleResearch

This study reports findings from a 56-year-old patient, who had received bilateral intravitreal injection of putative adipose tissue-derived stem cells at a private clinic in India with the promise of treatment of NAION. During an observation period of 8, respectively, 18 months, the intravitreally injected cells remained silent in the vitreous bodies without either therapeutic effects or complications. The cells cleared with vitrectomy without evidence of integration in the optic nerve or retina. Contrary to recent reports on patients receiving intravitreal injections of similar putative stem cells with the aim of treating AMD, our patient suffered no devastating ocular consequences. Summary. Contrary to recent reports, this case demonstrated no devastating consequences of intravitreal injection of adipose tissue-derived stem cells during an observation period of up to 18 months. After vitrectomy, the cells cleared without evidence of either harm or integration.

Original languageEnglish
Article number6927829
JournalCase Reports in Ophthalmological Medicine
Volume2019
Number of pages4
ISSN2090-6722
DOIs
Publication statusPublished - Dec 2019

Number of downloads are based on statistics from Google Scholar and www.ku.dk


No data available

ID: 240980403